Insights / News

MIT Horizon spotlights Controlant

In a recent interview with MIT Horizon, Erlingur Brynjúlfsson, Chief Strategy Officer and co-founder, sheds light on how Controlant’s real-time monitoring solutions enable the safe, efficient, and sustainable delivery of medicines and vaccines while eliminating waste and ensuring patient safety.

Published:
facebooktwitterlinkedin
The picture shows a screenshot from the pharma-compliant Aurora platform with a reusable Saga IoT device. Controlant is a global leader in the digital transformation of pharma supply chains, offering real-time monitoring solutions that include the Aurora cloud platform, advanced IoT devices, and dedicated services.

Erlingur highlights that the “consistent flow of high-quality data“ is key in driving decision-making in pharma supply chains to prevent waste and ensure patient safety.  

The article covers Controlant’s role in supporting the delivery of more than 6 billion Covid-19 vaccine doses to global destinations, and the company’s vision of enabling zero-waste pharma supply chains in collaboration with the world’s leading pharmaceutical companies and logistics service providers. 

MIT Horizon offers an exclusive library, events, and workshops that provide the continuous learning a global workforce needs to understand and leverage today's innovations. 

MIT Horizon case study in 2024 with Erlingur Brynjulfsson on using IoT to trace shipments of medicines and vaccines in the pharma supply chain.